Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results
22 avr. 2015 07h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., April 22, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Discuss First Quarter Business Performance on April 22, 2015
13 avr. 2015 16h56 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., April 13, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit
09 mars 2015 17h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., March 9, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014
25 févr. 2015 07h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated, commercial stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for the Fiscal Period Ended December 31, 2014 on February 25, 2015
12 févr. 2015 22h11 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference
12 janv. 2015 19h40 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Management Adopts 10b5-1 Trading Plans
19 déc. 2014 15h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 19, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Announces Key Senior Management and Director Appointments
09 déc. 2014 17h50 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing...
Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End
09 déc. 2014 17h28 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences
12 nov. 2014 16h30 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...